BioInformant specializes in global strategic reports for the stem cell industry. As a specialty research company, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth.
3 Attributes that Distinguish BioInformant’s Stem Cell Industry Data
1) We are the only market research company that has served the stem cell sector since it emerged
Founded in 2006 in Washington, DC, by Cade Hildreth, our singular focus on the stem cell industry allows us to produce data that enables you to better understand your markets, competitors, and customers.
While other publishers are often broad-scale publishers that cover a range of industry topics, we specialize in stem cell industry data. In contrast to other research firms, BioInformant has been collecting data on the stem cell industry for the past 12 years. This means we have numerous 5-year periods for which we made stem cell industry projections and can compare our “projected” results to what “actually” occurred within the industry.
When choosing a provider of stem cell market intelligence, you should choose a research firm which has been tested and validated by both the market and the test of time.
2) BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CIRM, Xconomy, AABB, and Vogue Magazine.
When choosing a provider of stem cell market intelligence, you should choose one that is widely trusted and referenced. Selecting a market research provider who is referenced by the media is a way to screen for authority, accuracy, and quality, because prominent news outlets require high-quality sources.
Unfortunately, all too many market research firms outsource report writing to low-cost providers overseas who know little (if anything) about the field and produce reports of very poor quality and relevancy.
In contrast, BioInformant was founded 12 years ago and is headquartered near Washington, DC, to be in proximity to the National Institutes of Health (NIH), the U.S. FDA, and the Maryland Biotech Corridor. We attend stem cell industry conferences across the U.S. and worldwide, chairing and presenting at many of them, and serve industry leading clients that include GE Healthcare, Goldman Sachs, PerkinElmer, Merck, and more.
Most importantly, our stem cell industry research is widely cited by news outlets that include the Wall Street Journal (WSJ), Nature Biotechnology, Medical Ethics, CIRM, Xconomy, AABB, and Vogue Magazine.
3) Our management team comes from a Bioinformatics background – the science of collecting and analyzing complex genetic codes
A third aspect that sets BioInformant apart is that our leadership team comes from a “Bioinformatics” background – the science of collecting and analyzing complex genetic codes. The field of Bioinformatics involves developing tools for managing and analyzing large quantities of biological data, such as the complete set of genes within a cell (Genomics), the complete set of proteins in a cell (Proteomics), and the complete set of compounds or substrates that are formed through enzymatic reactions within living systems (Metabolomics).
All of these areas involve huge, complex data-sets that must be examined in order to identity critical information. We are trained in applying these advanced research techniques to the field of market research.
It is this expertise in “Bioinformatics” from which we derived our company name, BioInformant.
Our skill set in Bioinformatics makes us uniquely positioned to:
- Define scope, definitions, and boundaries for the stem cell industry
- Collect relevant data from within this expansive system
- Extract relevant and critical information
- Identify key trends for purposes of predicting future activity
Additionally, we are uniquely suited to managing complex search queries within large global databases. Within the stem cell industry, this allows us to derive critical trend rate data from scientific publication databases, clinical trial databases, patent databases, grant funding databases, public blood/cell/tissue registries, transplant registries, and more.
In summary, Bioinformatics is an interdisciplinary field that develops methods and tools for processing complex biological data, while Market Research is an interdisciplinary field that develops methods and tools for analyzing complex industry data. When performed effectively, these fields share most of the same techniques.
As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
To view BioInformant products, visit our Shop.